{"abstract":"The Food and Drug Administration (FDA or Agency) is announcing the availability of the draft guidance entitled \"Select Updates for the Breakthrough Devices Program Guidance: Reducing Disparities in Health and Healthcare.\" FDA has developed this draft guidance to propose select updates to the guidance that clarify how the program may be applicable to certain medical devices that provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions in populations impacted by health and/or healthcare disparities. This draft guidance is not final nor is it for implementation at this time.","action":"Notice of availability.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2022/10/21/2022-22878.html","cfr_references":[],"citation":"87 FR 64057","comment_url":null,"comments_close_on":"2022-12-20","correction_of":null,"corrections":[],"dates":"Submit either electronic or written comments on the draft guidance by December 20, 2022 to ensure that the Agency considers your comment on this draft guidance before it begins work on the final version of the guidance.","disposition_notes":null,"docket_ids":["Docket No. FDA-2022-D-1061"],"dockets":[{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2022-10-21","updated_at":"2023-02-27T20:07:31.335-05:00","comment_url":"https://www.regulations.gov/commenton/FDA-2022-D-1061-0001","allow_late_comments":null,"id":"FDA-2022-D-1061-0001","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2022-D-1061","title":"Select Updates for the Breakthrough Devices Program Guidance: Reducing Disparities in Health and Health Care; Draft Guidance for Industry and Food and Drug Administration Staff; Availability"}],"document_number":"2022-22878","effective_on":null,"end_page":64058,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2022/10/21/2022-22878.xml","html_url":"https://www.federalregister.gov/documents/2022/10/21/2022-22878/select-updates-for-the-breakthrough-devices-program-guidance-reducing-disparities-in-health-and","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2022-22878?publication_date=2022-10-21","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2022-10-21/2022-22878/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":773,"last_updated":"2026-07-26 00:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2022-10-21/pdf/2022-22878.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2022-22878.pdf?1666269927","publication_date":"2022-10-21","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2022/10/21/2022-22878.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_count":0,"agency_id":"FDA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2022-D-1061","supporting_documents_count":0,"docket_id":"FDA-2022-D-1061","document_id":"FDA-2022-D-1061-0001","regulation_id_number":null,"title":"Select Updates for the Breakthrough Devices Program Guidance: Reducing Disparities in Health and Health Care; Draft Guidance for Industry and Food and Drug Administration Staff; Availability","checked_regulationsdotgov_at":"2023-02-28T01:07:30Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":64057,"subtype":null,"title":"Select Updates for the Breakthrough Devices Program Guidance: Reducing Disparities in Health and Healthcare; Draft Guidance for Industry and Food and Drug Administration Staff; Availability","toc_doc":"Select Updates for the Breakthrough Devices Program; Reducing Disparities in Health and Healthcare","toc_subject":"Guidance:\n","topics":[],"type":"Notice","volume":87}